NIH drug development consulting services

Ended Purchase Order Awarded Jun 20, 2011 Last action Aug 4, 2020

Contract number: HHSN271201100386P
Awardee: Pearson Pharma Partners UEI TJN3M3UNJF15
Awarding agency: National Institute on Drug Abuse National Institutes of Health, Department of Health and Human Services
Obligated: $173,268

Award facts

Contract value 100% obligated: $173,268.22 Current and potential, with all options
Completion date 100% complete: Feb 28, 2016 Current and potential, with all options
NAICS code: 541690 Other Scientific and Technical Consulting Services
PSC: AN11 Health R&D Services; Health Care Services; Basic Research
Set-aside: No set-aside
Competition: Competed under SAP · 10 offers Simplified Acquisition
Pricing: Firm Fixed Price
Place of performance: Thousand Oaks, CA 91362, USA

Award details come from SAM.gov/FPDS.

Action	Obligated	Date
Funding Only Action P00014 · NIH drug development and consulting services	-$30,960	Aug 4, 2020
Funding Only Action P00013	-$26,370	May 15, 2019
Other Administrative Action 12 · The purpose of modification 00011 is complete the administrative and financial DE-obligations for the FY 13 expiring lines closeout.	-$26,384	Aug 12, 2018
Funding Only Action 11 · Final_close_process -the purpose of modification 00010 is complete the administrative and financial DE-obligations for the FY 12 expiring lines closeout.	-$1,458	May 18, 2017
Other Administrative Action 10 · The purpose of modification 00010 is complete the administrative and financial DE-obligations for the FY 12 expiring lines closeout.	-$1,560	May 18, 2017
Exercise an Option 9	$36,000	Mar 4, 2015
Other Administrative Action 8 · R & D- medical: biomedical (basic research)	$0	Feb 9, 2015
Exercise an Option 7	$36,000	Jan 31, 2014
Exercise an Option 6	$36,000	Aug 6, 2013
Exercise an Option 5	$36,000	Mar 21, 2013
Funding Only Action 4	$4,000	Dec 31, 2012
Funding Only Action 3	$36,000	Dec 10, 2012
Exercise an Option 2	$36,000	Mar 6, 2012
Exercise an Option 1	$22,000	Nov 15, 2011
Original award	$18,000	Jun 20, 2011

Show all 15

HHSN271201100386P was awarded to Pearson Pharma Partners by National Institute on Drug Abuse (National Institutes of Health) on June 20, 2011.

The government has obligated $173,268 on HHSN271201100386P.

The extent of competition for HHSN271201100386P was competed under sap. The government received 10 offers.

On GovTribe

Try for free Login